stockrowAbsci Corporation (ABSI) vs Agios Pharmaceuticals, Inc. (AGIO)
- Absci Corporation ABSI 10.17 +8.31%
- Agios Pharmaceuticals, Inc. AGIO 29.41 +4.03%
Absci Corporation and Agios Pharmaceuticals, Inc. are both Biotechnology companies. Absci Corporation and Agios Pharmaceuticals, Inc. are of similar size ($1.7B and $1.6B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 214.4% against −62.3%. Agios Pharmaceuticals, Inc. has the higher net margin (−264.8% vs −7,756.4%) and the higher return on invested capital (−75.0% vs −174.7%). Across the 18 metrics below, Agios Pharmaceuticals, Inc. leads on 11 and Absci Corporation on 7.
Valuation
Profitability
| Metric | ABSI | AGIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.81% | 68.51% |
| Operating margin | (8,084.50%) | (297.72%) | 0.00% |
| Net margin | (7,756.37%) | (264.76%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (238.54%) | 0.00% |
| Return on equity | (57.72%) | (32.95%) | (51.96%) |
| Return on assets | (50.57%) | (30.44%) | (46.06%) |
| Return on invested capital | (174.74%) | (75.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack